A

Alkermes plc
D

ALKS

29.750
USD
-0.22
(-0.73%)
Market Closed
Volume
112,169
EPS
2
Div Yield
-
P/E
13
Market Cap
4,813,624,613
OverviewSignalsIdeasNews
Related Instruments
    A
    AAL
    0.220
    (1.32%)
    16.870 USD
    A
    ALGT
    2.230
    (2.72%)
    84.330 USD
    A
    ALK
    1.120
    (1.72%)
    66.070 USD
    DAL
    DAL
    0.530
    (0.88%)
    60.910 USD
    H
    HA
    0.690
    (3.99%)
    18.000 USD
    J
    JBLU
    0.13500
    (1.85%)
    7.43000 USD
    L
    LUV
    0.470
    (1.43%)
    33.270 USD
    S
    SAVE
    -0.24000
    (-18.18%)
    1.08000 USD
    U
    UAL
    1.870
    (1.96%)
    97.440 USD
    More
News

Title: Alkermes plc

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.